Joan Montero
banner
joanmontero.bsky.social
Joan Montero
@joanmontero.bsky.social
Associate Professor at University of Barcelona (Campus Clínic). Leading the Cell death, senescence and cancer precision medicine lab. Group Leader at IDIBAPS. ICREA Acadèmia awardee. Former IBEC/DFCI/HMS. Board member of the SfPM. www.themonterolab.com
Excited to share our new paper in @oncogenesisnature.bsky.social Prostate cancer cells acquire BCL-xL dependence during docetaxel treatment, that can be targeted with BCL-xL inhibitors/degraders. Especially grateful to Clara Alcon for her dedication in this project.
www.nature.com/articles/s41...
Dual downregulation of HRK and BAD promotes BCL-xL-mediated docetaxel resistance in prostate cancer - Oncogenesis
Oncogenesis - Dual downregulation of HRK and BAD promotes BCL-xL-mediated docetaxel resistance in prostate cancer
www.nature.com
August 21, 2026 at 9:14 AM
Excited to share our latest methods review on senescence! 🧬We map apoptotic dependencies in senescent cells using BH3 profiling + p16/p21 to guide senolytics. Targeting BCL‑2 family could boost clearance & therapy outcomes. @ub.edu
@idibaps.bsky.social

authors.elsevier.com/a/1nHlF,25QI...
tinyurl.com
June 17, 2026 at 12:13 PM
#InternationalChildhoodCancerDay we raise awareness, honor children and families, & reaffirm our commitment to science that saves live by continue working to develop tools that improve therapeutic decision‑making to bring the best treatment to every child www.themonterolab.com
Home | Montero Lab
The Montero Lab at the University of Barcelona's Department of Biomedical Sciences is dedicated to exploring the biology of cancer metastasis.
www.themonterolab.com
February 15, 2026 at 11:20 AM
On #WorldCancerDay, we reaffirm our dedication to understand how cancers develop resistance to therapy and to advancing new functional precision medicine technologies to overcome it. Our mission remains clear: to drive the discovery of more effective treatments for adult and pediatric cancers.
February 4, 2026 at 3:39 PM
Gracias por todas esas canciones que han marcado un antes y un después en mi vida. DEP Robe
December 10, 2025 at 9:22 PM
Are you attending the American Society of Hematology meeting? Don't miss this session led by SfPM member Dr. Pamela Becker and St. Jude's

Integrating Functional and Genomic Precision Medicine for Hematologic Malignancies.

Friday, December 5, 2025, 3:00-6:00 PM
December 5, 2025 at 3:59 PM
Happy Thanksgiving to all my American friends!
November 27, 2025 at 8:03 AM
Congratulations @senescel.org for this great meeting! Total success! Dr. Clara Alcon presented our work focused on TIS-mediated resistance, and how to detect it using BH3 profiling and overcome it targeting anti-apoptotic proteins. Can’t wait for the next meeting!
November 8, 2025 at 8:50 AM
Reposted by Joan Montero
🚨Excited to announce the seminar by Kushtrim Kryeziu, PhD (Oslo University) on "Functional Precision Oncology for Metastatic Colorectal Cancer". Join us TODAY, at 12 PM EDT, open to everyone! Don't miss it and consider joining the SFPM

www.sfpm.io/seminars
Seminars | SFPM
The SFPM Seminar series is for those interested in the use of assaying technology to further biomarker discovery, drug R&D and personalized healthcare outcomes.
www.sfpm.io
October 8, 2025 at 11:10 AM
Reposted by Joan Montero
#RecercaUB | 🧠 Un nou estudi aconsegueix revertir els efectes de l’Alzheimer en ratolins amb l’ús de nanopartícules portadores de molècules terapèutiques.

🔬 Hi han participat Lorena Ruiz Pérez, de #FísicaUB, i Giuseppe Battaglia, tots dos membres @ibecbarcelona.eu.
Aconsegueixen revertir l’alzheimer en ratolins amb l'ús de nanopartícules - Institute for Bioengineering of Catalonia
Un equip internacional codirigit per l'Institut de Bioenginyeria de Catalunya (IBEC) i l'Hospital West China de la Universitat de Sichuan (WCHSU) va poder revertir l'Alzheimer en ratolins després de n...
ibecbarcelona.eu
October 7, 2025 at 1:13 PM
Congratulations Tony! I wish you every success in this new endeavor and I have no doubt that your vision, leadership and integrity will bring great value to the NCI. I'm deeply grateful for your invaluable mentorship, friendship and encouragement over the years. Amazing news!
We want to congratulate our President, Dr. Tony Letai, on his appointment as Director of the NCI. This announcement marks an historic moment for cancer research. Dr. Letai has been a tireless advocate and visionary leader for functional precision medicine 🧵

www.nih.gov/news-events/...
Secretary Kennedy Swears in Dr. Anthony Letai as Director of the National Cancer Institute
Dr. Letai will serve as NCI’s 18th director.
www.nih.gov
September 30, 2025 at 6:09 AM
A must watch video: How functional precision medicine could be the future of cancer care. Truly inspiring TED talk by Dr. Diana Azzam

www.youtube.com/watch?v=CqLC...
How functional precision medicine could be the future of cancer care | Dr. Diana Azzam | TEDxMiami
YouTube video by TEDx Talks
www.youtube.com
August 26, 2025 at 11:04 AM
Delighted to see good research highlighted on TV @som.3cat.cat
Congratulations @tceliaterrassa.bsky.social and team! Hope your findings help to better treat metastatic breast cancer patients.
www.3cat.cat/324/cancer-d...
Càncer de mama: identifiquen les cèl·lules que actuen com a llavors de la metàstasi
Investigadors de l'Hospital del Mar vinculen per primer cop una proteïna a la metàstasi en el càncer de mama i obren la porta a tractaments preventius
www.3cat.cat
July 11, 2025 at 1:16 PM
Reposted by Joan Montero
This is going to be a really cool meeting with great invited speakers, but also offering the possibility to showcase your work independently of your career stage.
It will also be loads of fun in Barcelona, with the most friendly and welcoming community ☺️
Rush to register at senescel2025.senescel.org
July 10, 2025 at 7:59 AM
✨ Excited to announce a talk by Rita Fior, PhD on "Zebrafish Avatars for Personalized Medicine & Discovery of Innate Immune Mechanisms"! Join us next Wednesday, July 9, 2025, at 12 PM EDT, organized by @thesfpm.bsky.social. Don't miss it!
www.sfpm.io/seminars
Seminars | SFPM
The SFPM Seminar series is for those interested in the use of assaying technology to further biomarker discovery, drug R&D and personalized healthcare outcomes.
www.sfpm.io
July 2, 2025 at 3:05 PM
🚨 New Article Alert! Dive into a fantastic review by several @thesfpm.bsky.social members on how new technologies and functional approaches are revolutionizing personalized cancer treatment. Don't miss out on this game-changing insight!

www.nature.com/articles/s41...
Acquired resistance in cancer: towards targeted therapeutic strategies - Nature Reviews Cancer
Acquired therapeutic resistance is a key contributor to cancer treatment failure, requiring new approaches to address its complex mechanisms. In this Roadmap, Soragni, Knudsen and colleagues discuss t...
www.nature.com
June 27, 2025 at 2:41 PM
Reposted by Joan Montero
Online now concurrent with the #AACR25 oral presentation by Cancer Discovery Early Career Award Winner @Sandra_Misale: Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations doi.org/10.1158/2159...
April 28, 2025 at 6:30 PM
Quote of the day: “If you think research is expensive, try disease.” Mary Lasker
April 15, 2025 at 10:14 AM
Excited to share our latest findings! 🫁 Dynamic BH3 profiling predicts ALK-TKI response in NSCLC, revealing new therapeutic combos to overcome resistance. Read the summary here:

web.ub.edu/en/web/actua...
New advances in the fight against the most common form of lung cancer
web.ub.edu
April 9, 2025 at 9:37 AM
Excited to share our latest findings! 🫁 Dynamic BH3 profiling predicts ALK-TKI response in NSCLC, revealing new therapeutic combos to overcome resistance. Congratulations to Dr. Martín and to all our collaborators
@ub.edu @ibecbarcelona.eu @hospitalclinic.bsky.social CIBERBBN
rdcu.be/eennu
Novel selective strategies targeting the BCL-2 family to enhance clinical efficacy in ALK-rearranged non-small cell lung cancer
Cell Death & Disease - Novel selective strategies targeting the BCL-2 family to enhance clinical efficacy in ALK-rearranged non-small cell lung cancer
rdcu.be
March 21, 2025 at 8:52 AM
Do not miss this great talk tomorrow at 5pm CET (12pm EDT): Zinaida Perova (EMBL) "Leveraging CancerModels.Org: Enhancing Precision Oncology Through Collaborative Cancer Model Resources". @thesfpm.bsky.social

www.sfpm.io/seminars
March 11, 2025 at 11:14 AM
Happy International Women’s day to all the brave, intelligent, loving, amazing women worldwide!
March 8, 2025 at 4:36 PM
🚀 Exciting news! Our new research lab website is live! 🌐 Explore cutting-edge projects, publications, and more. Visit us at themonterolab.com
Home | Montero Lab
The Montero Lab at the University of Barcelona's Department of Biomedical Sciences is dedicated to exploring the biology of cancer metastasis.
themonterolab.com
February 13, 2025 at 10:40 AM
Reposted by Joan Montero
Papers on cell death from January 2025
Caspases, pyroptosis, apoptosis, cytotoxicity, ferroptosis, necroptosis, Bcl-2 family and more!
ApoList
celldeath.wordpress.com/2025/02/04/a...
ApoList – January 2025
Caspases TIR signaling activates caspase-like immunity in bacteria – François Rousset, Ilya Osterman, Tali Scherf, Alla H. Falkovich, Azita Leavitt, Gil Amitai, Sapir Shir, Sergey Malitsky, M…
celldeath.wordpress.com
February 4, 2025 at 5:31 PM
On #WorldCancerDay #WCD2025 and every day, our lab is committed to finding a cure for cancer through groundbreaking research and advanced functional precision medicine. Together, we can find a treatment for each patient and beat cancer @ub.edu @thesfpm.bsky.social
February 4, 2025 at 10:30 AM